Condition
Autosomal Dominant Polycystic Kidney clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Autosomal Dominant Polycystic Kidney clinical trials that are recruiting, at sites in 3 countries (most in United States (2), Italy (2), Netherlands (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Autosomal Dominant Polycystic Kidney clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Database analysis of patients with Autosomal Dominant Polycystic Kidney Disease | — | Bologna | Recruiting | Jan 6, 2025 |
| Using a medication to slow kidney growth in patients with a genetic kidney disease | Phase 2 | Aurora, Colorado | Recruiting | Sep 3, 2024 |
| Using RNA sequencing to diagnose rare genetic diseases | — | Ranica, BG | Recruiting | Aug 18, 2023 |
| Using a GnRH Agonist to Treat Severe Polycystic Liver Disease in Women | Phase 2 | Nijmegen, Gelderland and 1 other locations | Recruiting | Jul 28, 2022 |
| Observing the effects of foam sclerotherapy on kidney and liver cysts | — | Rochester, Minnesota | Recruiting | Oct 1, 2019 |
All recruiting trials (5)
-
Database analysis of patients with Autosomal Dominant Polycystic Kidney Disease
This study is trying to gather and track health information from people with Autosomal Dominant Polycystic Kidney Disease to see how different treatments affect their kidney function and cyst growth over time.
-
Using a medication to slow kidney growth in patients with a genetic kidney disease
This study is testing if a new medication can help slow down kidney growth in overweight or obese adults with a genetic kidney disease called ADPKD.
-
Using RNA sequencing to diagnose rare genetic diseases
This study is testing if a new RNA sequencing method can help find the genetic causes of rare diseases in people who haven't been diagnosed after other tests.
-
Using a GnRH Agonist to Treat Severe Polycystic Liver Disease in Women
This study is testing if a medication called leuprorelin can help reduce liver size in women with severe polycystic liver disease who are still experiencing growth despite other treatments.
-
Observing the effects of foam sclerotherapy on kidney and liver cysts
This study is testing if foam sclerotherapy can help reduce the size of large kidney and liver cysts in people with polycystic kidney and liver diseases and improve their quality of life over a year.
Related topics
Quick answers
How many Autosomal Dominant Polycystic Kidney clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (2 trials), Italy (2 trials), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.